KRYS
Krystal Biotech, Inc.
Nasdaq: KRYS · Pittsburgh, PA · Healthcare
$335.19+7.69 (+2.35%)Closed
Market Cap$9.87B
Cash$501.3Mmost recent
Runwayprofitable
P/E (TTM)49.0EPS $6.84
52-Wk Range$134.94 – $378.15
Avg Volume339.3K3-month
Price & Trading Activity
Daily close with catalyst overlays and trading volume
$335.19+59.1%
Pipeline
Drug candidates sponsored by KRYS · ClinicalTrials.gov
Couldn't load pipeline. ClinicalTrials.gov or the backend may be unavailable.
Valuation
Risk-adjusted NPV
Loading pipeline…
Peer comparison
Cohort check
No peer cohort defined for KRYS. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.